LISMORE, AUSTRALIA – 15 October 2020 – Lismore-based CannaPacific, a biopharmaceutical company focused on medicinal cannabis, announced today an initiative to grow and donate 60,000 tube stock native plants annually for local regeneration projects in their cultivation and research facility near Lismore. This project is supported by environmental enterprise, Greening Australia, who will be providing native seed to the initiative.
Joshua Dennis, CEO of CannaPacific, has forged a strong relationship with Greening Australia with an aspiration to become a part of restoration efforts in Australia. “We share the enthusiasm of Greening Australia, the Australian government and the broader community in wanting to see the regeneration of our unique native forests, and the restoration of the natural habitat for our native animals and birds.
CannaPacific’s agreement with Greening Australia will enable us to contribute through growing and maintaining approximately 60,000 native tube stock plants annually to an advanced stage of growth on our Lismore property. Once the trees are ready to be placed in local projects, this would produce plantings equivalent in size to 2500 football fields per year. That’s a real win for the environment.” said Joshua Dennis today.
In the wake of the horrific fires that devastated the Australian landscape, Greening Australia with expertise in the seed space, were appointed by the Federal Government to lead the development of a strategic program to build and secure native seed and plant supply for landscape restoration.
Commenting on the recent events of horrendous bushfires, distressing scenes of native animals struggling to survive, and the current pandemic, Joshua said “Those events have been truly terrible. It’s a fragile world that we live in. We see plants in the ground as a big part of the solution in helping our native flora and fauna to regenerate and to stop erosion.”
CannaPacific is an Australian biotechnology company focused on the cannabinoid pharmaceutical sector. By combining advanced molecular breeding technology with a traditional approach to drug development, CannaPacific seeks to build a global therapeutic offering with an initial focus on palliative care and post-traumatic stress disorder.
CannaPacific’s strategy is to attain a world-leading position in the field of cannabinoid science through the research, development and commercialisation of cannabinoid molecules as authorised pharmaceutical products.
CannaPacific operates a cultivation facility nestled in the beautiful Byron Bay hinterland in northern NSW. The production facility includes a 10,000 sqm Dutch glasshouse and high-security outdoor cultivation area.
About Greening Australia:
Greening Australia has been restoring and conserving Australia’s unique landscapes at scale through collaborative, science-based and innovative programs for over 38 years. Greening Australia is committed to tackling Australia’s greatest environmental challenges in ways that work for communities, economies and nature; planting millions of native trees and plants, protecting hundreds of native species, and supporting Traditional Owners aspirations for restoring country. For more information, visit www.greeningaustralia.org.au